1-O-alkyl glycerophosphate-induced CD36 expression drives oxidative stress in microglial cells

Tamotsu Tsukahara1

  • 1Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, 1-14 Bunkyo-machi, Nagasaki, 852-8521 Japan.

Cellular Signalling
|November 1, 2019
PubMed

Insights

1-O-alkyl glycerophosphate (AGP) activates peroxisome proliferator-activated receptor gamma (PPARγ) in microglia. This activation enhances cluster of differentiation 36 (CD36) expression and increases reactive oxygen species (ROS) production.

Area of Science:

  • Neuroimmunology
  • Cellular and Molecular Neuroscience
  • Inflammation Research

Background:

  • Microglia are central nervous system macrophages crucial for neuroinflammation.
  • Peroxisome proliferator-activated receptor gamma (PPARγ) regulates fatty acid metabolism and immune responses.
  • 1-O-alkyl glycerophosphate (AGP) is a high-affinity, partial agonist of PPARγ.

Purpose of the Study:

  • To investigate the role of AGP in microglial activation.
  • To elucidate the molecular mechanisms underlying AGP's effects on microglia.

Main Methods:

  • Treatment of microglial cells with AGP.
  • Measurement of intracellular reactive oxygen species (ROS) production.
  • Assessment of PPARγ activation and cluster of differentiation 36 (CD36) expression levels.

Main Results:

  • AGP treatment increased intracellular ROS production in microglial cells.
  • AGP induced PPARγ activation within microglial cells.
  • AGP up-regulated the expression of the CD36 scavenger receptor.

Conclusions:

  • AGP modulates microglial activation through PPARγ-dependent pathways.
  • AGP enhances CD36 expression and ROS production in microglia.
  • These findings provide insights into AGP's potential role in neuroinflammatory processes.

Related Concept Videos